Business Context and Reporting Period
Company: Alterity Therapeutics Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of April 2020
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
This filing incorporates by reference Appendix 4C and a Quarterly Update into the company's Registration Statements on Form S-8 and Form F-3. The document was signed by Geoffrey Kempler, Executive Chairman, on April 30, 2020.
Key Financial Metrics
The provided filing text does not contain specific financial data. No values are reported for revenue, profit, cash flow, margins, debt, or liquidity in this excerpt.
Material Changes
The filing text does not provide details regarding material changes versus the prior comparable period. The document serves primarily as a cover sheet to incorporate other reports by reference.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, specific risks, contingencies, or unusual items. These details are contained within the referenced Appendix 4C and Quarterly Update, which are not included in the provided text.
Investor Verification Checklist
- Verify the contents of the referenced "Appendix 4C and Quarterly Update" for actual financial performance and operational updates.
- Confirm the status of the Registration Statements on Form S-8 (File No. 333-228671) and Form F-3 (Files No. 333-220886 and 333-231417) into which this report is incorporated.
- Review the full text of the referenced documents to assess any material risks or changes in the company's business strategy.